Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer

被引：78

作者：

Hortobagyi, GN ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 06期

关键词：

D O I：

10.1053/sonc.2001.29710

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：43 / 47

页数：5

共 55 条

[1]

[Anonymous], P AM SOC CLIN ONCOL

[2]

Baselga J., 1994, Breast Cancer Research and Treatment, V32, P30

[3] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].

Baselga, J ;

Tripathy, D ;

Mendelsohn, J ;

Baughman, S ;

Benz, CC ;

Dantis, L ;

Sklarin, NT ;

Seidman, AD ;

Hudis, CA ;

Moore, J ;

Rosen, PP ;

Twaddell, T ;

Henderson, IC ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744

[4]

Baselga J, 1998, CANCER RES, V58, P2825

[5]

Burris HA, 2000, SEMIN ONCOL, V27, P19

[6]

Burstein H. J., 1999, Breast Cancer Research and Treatment, V57, P29

[7] c-erbB2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases [J].

Carlomagno, C ;

Perrone, F ;

Gallo, C ;

DeLaurentiis, M ;

Lauria, R ;

Morabito, A ;

Pettinato, G ;

Panico, L ;

DAntonio, A ;

Bianco, AR ;

DePlacido, S .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2702-2708

[8] HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J].

CARTER, P ;

PRESTA, L ;

GORMAN, CM ;

RIDGWAY, JBB ;

HENNER, D ;

WONG, WLT ;

ROWLAND, AM ;

KOTTS, C ;

CARVER, ME ;

SHEPARD, HM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4285-4289

[9] Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease [J].

Cobleigh, MA ;

Vogel, CL ;

Tripathy, D ;

Robert, NJ ;

Scholl, S ;

Fehrenbacher, L ;

Wolter, JM ;

Paton, V ;

Shak, S ;

Lieberman, G ;

Slamon, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2639-2648

[10]

COBLEIGH MA, 1998, P AN M AM SOC CLIN, V17, P97

← 1 2 3 4 5 6 →